| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| ACCOUNTING FEES | 9,500 | 4,750 | 4,750 |
| Grantee's Name | Grantee's Address | Grant Date | Grant Amount | Grant Purpose | Amount Expended By Grantee | Any Diversion By Grantee? | Dates of Reports By Grantee | Date of Verification | Results of Verification |
|---|---|---|---|---|---|---|---|---|---|
|
NEMDX INC |
2000 COMMONWEALTH AVE AUBURNDALE,MA02466 |
2024-07-02 | 135,324 | TO ASSIST STUDIES IN FINDING A CURE OF ALS. | 135,324 | TO THE KNOWLEDGE OF THE GRANTOR, NO FUNDS HAVE BEEN DIVERTED. | 07/02/24 | 2024-12-31 | THE GRANTOR HAS NO REASON TO DOUBT THE ACCURACY OR RELIABILITY OF THE REPORT FROM THE GRANTEE; THEREFORE, NO INDEPENDENT VERIFICATION OF THE REPORT WAS MADE. |
| Identifier | Return Reference | Explanation |
|---|---|---|
| MISSION RELATED INVESTMENT | 990-PF, PART II, LINE 13 | IN 2016, THE FOUNDATION ENTERED INTO A STOCK PURCHASE AGREEMENT WITH A FOR PROFIT ENTITY, EMULATE, INC., PURCHASING 2,000,000 SHARES OF SERIES B PREFERRED STOCK. THE COMPANY CREATED A TECHNOLOGY THAT EMULATES HUMAN BIOLOGY TO AID IN THE UNDERSTANDING OF HOW DISEASES, MEDICINES, CHEMICALS AND FOODS AFFECT HUMAN HEALTH. THE APPLICATION OF SUCH TECHNOLOGY IS EXPECTED TO AID IN THE RESEARCH AND CURE THE DISEASE (INCLUDING ALS), WHICH IS IN FURTHERANCE OF THE FOUNDATION'S EXEMPT PURPOSES. VALUE IS DETERMINED BY THE MOST RECENT SALE OF THE STOCK BY OTHER OWNERS USING THE PRICE AND ENTERED AS AN UNREALIZED GAIN. |
| Name of Bond | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMAZON COM INC | 183,558 | 183,558 |
| APPLE INC | 383,104 | 383,104 |
| BARCLAYS BK PLC | 89,445 | 89,445 |
| BK OF AMER CORP | 1,384,826 | 1,384,826 |
| CHEVRON USA INC | 394,792 | 394,792 |
| CITIGROUP INC | 343,030 | 343,030 |
| COCA-COLA CO | 233,677 | 233,677 |
| COSTCO WHSL CORP | 85,888 | 85,888 |
| CRDT SUISSE AG LONDON | 254,548 | 254,548 |
| GOLDMAN SACHS GROUP INC | 974,678 | 974,678 |
| JOHNSON & JOHNSON | 455,002 | 455,002 |
| JP MORGAN CHASE & CO | 719,669 | 719,669 |
| MERCK & CO INC | 83,936 | 83,936 |
| PFIZER INC | 443,418 | 443,418 |
| PROCTER & GAMBLE CO | 242,474 | 242,474 |
| TORONTO - DOMINION BK | 423,613 | 423,613 |
| UBS AG | 353,938 | 353,938 |
| VERIZON COMMUNICATIONS | 82,306 | 82,306 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AMAZON.COM INC (AMZN), 2,000 SHARES | 438,780 | 438,780 |
| APPLE INC (AAPL), 24,000 SHARES | 6,010,080 | 6,010,080 |
| JPMORGAN CHASE & CO (JPM), 1,000 SHARES | 239,710 | 239,710 |
| MORGAN STANLEY (MS), 5,000 SHARES | 628,600 | 628,600 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| INVESCO QQQ TRUST ETF (QQQ), 10,635 SHARES | FMV | 5,436,931 | 5,436,931 |
| MISSION RELATED INVESTMENT | FMV | 6,600,000 | 6,600,000 |
| SPDR S&P 500 ETF TR (SPY), 4,101 SHARES | FMV | 2,403,514 | 2,403,514 |
| AMERICA FIRST NATURAL RESOURCES LLC | AT COST | 1,000,000 | 1,000,000 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| OFFICE EXPENSES | 3,401 | 0 | 1,701 | |
| BANK FEES | 226 | 226 | 0 |
| Description | Amount |
|---|---|
| UNREALIZED GAIN ON SECURITIES | 3,099,742 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| CONSULTING FEES | 245,239 | 0 | 245,239 |
| Name | Address |
|---|---|
|
LEANDRO P RIZZUTO CL ANNUITY TRUST |
ONE CUMMINGS POINT RD STAMFORD,CT06902 |
| DENIS RIZZUTO |
124 CLIPPER LANE JUPITER,FL33477 |
|
NFL FOUNDATION |
C/O ANNA ISAACSON 345 PARK AVENUE NEW YORK,NY10065 |
|
LEANDRO RIZZUTO |
1014 GATEWAY BLVD SUITE 105 BOYNTON BEACH,FL33426 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXCISE TAX | 28,767 | 0 | 0 |